Clinical trial
Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder
NCT02660528
Study timeline
Study start (actual)2016-04-01Date precision: month
Registry last updated2020-10-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
TocilizumabDRUG · verified · RxNorm: tocilizumab
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02660528 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.